Ident. | Authors (with country if any) | Title |
---|
001292 (2011) |
Karl Kieburtz [États-Unis] | Twice‐daily, low‐dose pramipexole in early Parkinson's disease: A randomized, placebo‐controlled trial |
001397 (2011) |
Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study Group [Allemagne, Afrique du Sud, Pologne, Hongrie, États-Unis, Nouvelle-Zélande, Finlande, Royaume-Uni, Italie, Espagne, Autriche] | Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) |
001438 (2011) |
John W. Winkelman [États-Unis] ; Richard K. Bogan [États-Unis] ; Markus H. Schmidt [États-Unis] ; John D. Hudson [États-Unis] ; Sarah E. Derossett [États-Unis] ; Christina E. Hill-Zabala [États-Unis] | Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome |
001491 (2011) |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
001543 (2011) |
Davide Chiasserini [Italie] ; Alessandro Tozzi [Italie] ; Antonio De Iure [Italie] ; Michela Tantucci [Italie] ; Federica Susta [Italie] ; Pier Luigi Orvietani [Italie] ; Keizo Koya [États-Unis] ; Luciano Binaglia [Italie] ; Paolo Calabresi [Italie] | Mortalin inhibition in experimental Parkinson's disease |
001605 (2011) |
Giovanna Zorzi [Italie] ; Federica Zibordi [Italie] ; Luisa Chiapparini [Italie] ; Enrico Bertini [Italie] ; Lidia Russo [Italie] ; Antonio Piga [Italie] ; Filomena Longo [Italie] ; Barbara Garavaglia [Italie] ; Domenico Aquino [Italie] ; Mario Savoiardo [Italie] ; Alessandra Solari [Italie] ; Nardo Nardocci [Italie] | Iron‐related MRI images in patients with pantothenate kinase–associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial |
001678 (2011) |
Francesco Saccà [Italie] ; Raffaele Piro [Italie] ; Giuseppe De Michele [Italie] ; Fabio Acquaviva [Italie] ; Antonella Antenora [Italie] ; Guido Carlomagno [Italie] ; Sergio Cocozza [Italie] ; Alessandra Denaro [Italie] ; Anna Guacci [Italie] ; Angela Marsili [Italie] ; Gaetano Perrotta [Italie] ; Giorgia Puorro [Italie] ; Antonio Cittadini [Italie] ; Alessandro Filla [Italie] | Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit |
001689 (2011) |
Stuart A. Yablon [États-Unis] ; Mitchell F. Brin [États-Unis] ; Amanda M. Vandenburgh [États-Unis] ; Jihao Zhou [États-Unis] ; Susan M. Garabedian-Ruffalo [États-Unis] ; Susan Abu-Shakra [États-Unis] ; Frederick C. Beddingfield Iii [États-Unis] | Dose response with onabotulinumtoxinA for post‐stroke spasticity: A pooled data analysis |
001710 (2011) |
Robert A. Hauser [États-Unis] ; Peggy Auinger [États-Unis] | Determination of minimal clinically important change in early and advanced Parkinson's disease |
001724 (2011) |
Robert A. Hauser [États-Unis] ; Aaron L. Ellenbogen [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Ann Hsu [États-Unis] ; Martin J. O'Connell [États-Unis] ; Nishit B. Modi [États-Unis] ; Hsuan-Ming Yao [États-Unis] ; Sherron H. Kell [États-Unis] ; Suneel K. Gupta [États-Unis] | Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease |
001770 (2011) |
Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada] | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
001963 (2010) |
Maria Nord [Suède] ; Peter Zsigmond [Suède] ; Anita Kullman [Suède] ; Kerstin Rstrand [Suède] ; Nil Dizdar [Suède] | The effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF |
001A20 (2010) |
| Safety and tolerability of high‐dosage coenzyme Q10 in Huntington's disease and healthy subjects |
001A22 (2010) |
Wayne A. Hening [États-Unis] ; Richard P. Allen [États-Unis] ; William G. Ondo [États-Unis] ; Arthur S. Walters [États-Unis] ; John W. Winkelman [États-Unis] ; Philip Becker [États-Unis] ; Richard Bogan [États-Unis] ; June M. Fry [États-Unis] ; David B. Kudrow [États-Unis] ; Kurt W. Lesh [États-Unis] ; Andreas Fichtner [Allemagne] ; Erwin Schollmayer [Allemagne] | Rotigotine improves restless legs syndrome: A 6‐month randomized, double‐blind, placebo‐controlled trial in the United States |
001A99 (2010) |
Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP‐treated common marmosets |
001B22 (2010) |
Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Andrew Christopher Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni] | Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP‐treated common marmosets |
001B37 (2010) |
Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
001C40 (2010) |
Rodger J. Elble [États-Unis] ; Oksana Suchowersky [Canada] ; Stephanie Shaftman [Canada, États-Unis] ; William J. Weiner [États-Unis] ; Peng Huang [États-Unis] ; Barbara Tilley [États-Unis] | Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease |
001C53 (2010) |
Yutaka Naito [Japon] ; Ko Matsuo [Japon] ; Yasumasa Kokubo [Japon] ; Yugo Narita [Japon] ; Hidekazu Tomimoto [Japon] | Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe? |
001D19 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
001D22 (2010) |
Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP‐macaque model of Parkinson's disease |